ArticlePloS one2026

Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease.

Joshua T Dearborn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.